Literature DB >> 2492839

Treatment of the terminal stages of breast cancer.

K Holli1, M Hakama.   

Abstract

To assess the intensity of and changes in diagnostic investigations and treatment in the terminal stages of breast cancer 555 patients in the area of Tampere University Central Hospital in whom breast cancer had been diagnosed from 1977 to 1980 were followed up for five years. The case notes for the last visit of 519 patients were analysed. The amount of diagnostic activity was similar for those who died and for the survivors. A higher proportion of women who died than of women who survived received treatment at the last follow up visit, and 2.6 times as many of those dying within one week of the last visit were given chemotherapy as were survivors with recurrent disease. Resources devoted to diagnostic investigations and treatment of cancer in terminally ill patients could be better used for care of the patients. This would be more likely to improve the patients' quality of life and conserve resources.

Entities:  

Mesh:

Year:  1989        PMID: 2492839      PMCID: PMC1835372          DOI: 10.1136/bmj.298.6665.13

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  5 in total

Review 1.  Cost versus benefit in non-surgical management of patients with cancer.

Authors:  A R Timothy; T Brewin; J Chamberlain; A Horwich; B Jennett; P Kind; R Maxwell; J Raftery; G Rees; P Selby
Journal:  BMJ       Date:  1988-08-13

2.  Survival of women with metastatic breast cancer at Yale from 1920 to 1980.

Authors:  M Todd; M Shoag; E Cadman
Journal:  J Clin Oncol       Date:  1983-06       Impact factor: 44.544

3.  Does more intense palliative treatment improve overall survival in metastatic breast cancer patients?

Authors:  J K Patel; T Nemoto; M Vezeridis; N Petrelli; O Suh; T L Dao
Journal:  Cancer       Date:  1986-02-01       Impact factor: 6.860

Review 4.  Chemotherapy of breast cancer: current views and results.

Authors:  G Bonadonna; P Valagussa
Journal:  Int J Radiat Oncol Biol Phys       Date:  1983-03       Impact factor: 7.038

5.  Failure of chemotherapy to prolong survival in a group of patients with metastatic breast cancer.

Authors:  T J Powles; R C Coombes; I E Smith; J M Jones; H T Ford; J C Gazet
Journal:  Lancet       Date:  1980-03-15       Impact factor: 79.321

  5 in total
  5 in total

1.  Beyond health outcomes: the benefits of health care.

Authors:  G Mooney
Journal:  Health Care Anal       Date:  1998-06

2.  [Janus-faced character of chemotherapy: a comment on the Abel theses].

Authors:  D Schmähl
Journal:  Klin Wochenschr       Date:  1991-01-04

3.  Continuity of the doctor/patient relationship during the routine follow-up of a breast cancer patient.

Authors:  K Holli; M Hakama
Journal:  Support Care Cancer       Date:  1993-09       Impact factor: 3.603

4.  Clinical management of women with metastatic breast cancer: a descriptive study according to age group.

Authors:  Klaartje Manders; Lonneke V van de Poll-Franse; Geert-Jan Creemers; Gerard Vreugdenhil; Maurice J C van der Sangen; Grard A P Nieuwenhuijzen; Rudi M H Roumen; Adri C Voogd
Journal:  BMC Cancer       Date:  2006-07-06       Impact factor: 4.430

5.  Advanced breast cancer and its prevention by screening.

Authors:  H J de Koning; B M van Ineveld; J C de Haes; G J van Oortmarssen; J G Klijn; P J van der Maas
Journal:  Br J Cancer       Date:  1992-06       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.